Riskpilot← Back to searchSign inGet full accessGxMed Nordic ApS
APSBankruptCVR 37089842Axeltorv 2, st.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20151 employeeswww.gxmednordic.com
Revenue 2022
DKK -145K
-125% vs 2021
EBITDA margin
100.0%
-125% vs 2021
Equity ratio
46.6%
Financial strength
Net profit 2022
DKK -118K
-111% vs 2021
| Revenue | DKK -145K | -125% |
| EBITDA | DKK -145K | -125% |
| Net profit | DKK -118K | -111% |
| Total assets | DKK 3,2M | -11% |
| Equity | DKK 1,5M | -7% |
| Employees | 1 | — |
Legal name
GxMed Nordic ApS
CVR number
37089842
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11. september 2015
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion eller af en direktør alene.
Company purpose
Selskabets formål er at drive virksomhed med salg og distribution af lægemidler samt at drive konsulentvirksomhed og anden virksomhed, der står i forbindelse hermed.
Address
Axeltorv 2, st.
Phone
+4539775013
Email
info@gxmednordic.com
Website
www.gxmednordic.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 2.633 | 193 | 4.641 | 572 | -145 |
| Staff expenses | -2.920 | -1.330 | -1.399 | -2 | -0 |
| EBITDA | -287 | -1.137 | 3.242 | 571 | -145 |
| Depreciation & amort. | -30 | -15 | -30 | -30 | -12 |
| EBIT | -317 | -1.152 | 3.212 | 541 | -157 |
| Net financials | -125 | -57 | -215 | -16 | -2 |
| Profit before tax | -442 | -1.209 | 2.997 | 524 | -160 |
| Tax | -0 | -0 | 660 | -532 | -42 |
| Net profit | -442 | -1.209 | 2.337 | 1.056 | -118 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 12.941 | 5.310 | 3.657 | 3.593 | 3.194 |
| Equity | 421 | -787 | 550 | 1.606 | 1.488 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12.519 | 6.098 | 3.107 | 1.987 | 1.706 |
| Total debt | 12.519 | 6.098 | 3.107 | 1.987 | 1.706 |
EBITDA margin
-14483400.0%
This company
15.8%
Market median
-91667189% vs market
20182022
Equity ratio
46.6%
This company
38.2%
Market median
+22% vs market
20182022
Return on equity
-7.9%
This company
18.4%
Market median
-143% vs market
20182022
Net profit margin
-11796100.0%
This company
8.1%
Market median
-145630964% vs market
20182022
Asset turnover
-0.05×
This company
1.12×
Market median
-104% vs market
20182022
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
20182022
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
MW Management | Management | 2015 – 2017 |
MC Chief Executive Officer | Chief Executive Officer | 2019 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2020 | |
| Company | 10–14.99% | 0% | 2019 | |
| Company | 100% | 100% | 2018 | |
| Individual | 50–66.65% | 50% | 2016 | |
| Individual | 50–66.65% | 50–66.65% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HHR HOLDING A/S
GxMed Nordic ApS Board members of GxMed Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Winstrøm | Management | 0 companies |
| Morten Carl Madsen | Chief Executive Officer | 0 companies |